arrow
M

Ming Ji

Chinese Academy of Medical Sciences and Peking Union Medical College
H指数:33
被引数:3,458

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals 2023, 16, 749

更正:Hou等人. S-72,一种新型口服可用微管抑制剂,通过抑制STING通路克服乳腺癌中的紫杉醇耐药性。 Pharmaceuticals 2023, 16, 749

2025-09-100
OAAI
Design, Synthesis, and Biological Evaluation of Novel Fms-Like Tyrosine Kinase 3/VEGFR2/Histone Deacetylase Inhibitors for the Treatment of Acute Myeloid Leukemia

新型Fms样酪氨酸激酶3/VEGFR2/组蛋白去乙酰化酶抑制剂的研制、合成及生物活性评价:用于急性髓系白血病的治疗

2025-02-190
PRE
Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota

蛋氨酸限制引起的硫缺乏症部分通过肠道微生物群损害抗肿瘤免疫力

2023-08-0325
OAAI
A novel murine model of mania
2023-03-299
OAAI